Download 1 Young Vision Scientist - vision

European Vision Research Groups
Questionnaire for the presentation of the European young vision scientists
Draft Version (2008-10-22)
1
Young Vision Scientist
Gender
female
male
Family Name:
First Name:
Title:
E-mail address:
CV as a PDF-file:
Please attach your CV (PDF)
Picture:
Please attach a picture (jpeg)
1.1. Business Address
Name of Institution:
Name of your research group:
Postal Address
Address:
Zip:
City:
Country:
Phone-Number:
Fax-Number:
Website:
EuroVisionNet – Portal / Presentation
Research Groups / Data
1/6
1.2. Current Research Projects
up to 5 lines of free text
1.3. Methodology
Methodology:
(up to 3 lines free-text)
1.4. Publications
Author(s)
Title / Journal
EuroVisionNet – Portal / Presentation
Research Groups / Data
2/6
Scientific Research
Topics
apoptosis/cell death
aqueous
astigmatism
(Tick up to 10
astrocyte
astrocytes: optic nerve head
keywords)
astroglia: optic nerve head
ACAID
autoimmune disease
Acanthamoeba
bacterial disease
accessory optic

system/pretectum
binocular vision/stereopsis
accomodation
bipolar cells
acetylcholine
blood supply
adaptation: blur
brightness and lightness
adaptation: chromatic
Bruch's membrane
adaptation: motion
calcium
adaptation: pattern
candidate gene analysis
adenosine
CAR
adenovirus
carbon dioxide
age-related macular
carbonic anhydrase

degeneration
carotenoids/carotenoid

aging
binding proteins
aging: visual performance
cataract
AIDS/HIV
cell adhesions/cell junctions
amacrine cells
cell-cell communication
amblyopia
cell membrane/membrane

specializations
amoeba
cell survival
anatomy
chaperones
anterior chamber
chorioretinitis
anterior segment
antibiotics/antifungals/antip choroid

arasitics
choroid: neovascularization
antigen
chromatic mechanisms

presentation/processing
ciliary body
antioxidants
ciliary muscle
antiviral drugs
ciliary processes
EuroVisionNet – Portal / Presentation Research Groups / Data
circadian rhythms
clinical (human) or
epidemiologic studies:

biostatistics/epidemiology
methodology
clinical (human) or
epidemiologic studies: health
care
delivery/economics/manpo
wer
clinical (human) or
epidemiologic studies:
natural history
clinical (human) or
epidemiologic studies:
outcomes/complications
clinical (human) or
epidemiologic studies:
prevalence/incidence
clinical (human) or
epidemiologic studies: risk
factor assessment
clinical (human) or
epidemiologic studies:

systems/equipment/techniq
ues
clinical (human) or
epidemiologic studies:
treatment/prevention
assessment/controlled
clinical trials
clinical laboratory testing
clinical research

methodology
color appearance/constancy
color pigments and opsins
color vision
comparative anatomy
computational modeling
conjunctiva
conjunctivitis
connecting cilium
constancy
contact lens
contrast sensitivity
cornea: clinical science
cornea: basic science
cornea: endothelium
cornea: epithelium
cornea: storage
cornea: stroma and

keratocytes
cornea: surface mucins
cornea: tears/tear film/dry

eye
corticosteroids
crystallins
cyclosporine
cytokines/chemokines
cytology
cytomegalovirus
cytoskeleton
degenerations/dystrophies
depth
detection
development
diabetes
diabetic retinopathy
disease gene mapping
differentiation
discrimination
dopamine
drug toxicity/drug effects
drusen
edema
eicosanoids
electrophysiology: clinical
electrophysiology: non
clinical
electroretinography: clinical
electroretinography: non
clinical
emmetropization
EMT (epithelial

mesenchymal transition)
endophthalmitis
enzymes/enzyme inhibitors
esotropia and exotropia
excitatory amino acid

receptors
excitatory neurotransmitters
extracellular matrix
extraocular muscles:

development
extraocular muscles:

structure
eye movements
eye movements: conjugate
eye movements: recording

techniques
eye movements: saccades

and pursuits
eyelid
face perception
fluorescent in situ

hybridization
flow cytometry
fungal disease
ganglion cells
gap junctions/coupling
gene/expression
gene microarray
gene modifiers
gene transfer/gene therapy
genetics
glaucoma
glia
glycoconjugates/glycoprotei

ns
grouping and segmentation
growth factors/growth factor

receptors
heading
herpes simplex virus
horizontal cells
hyperopia
hypoxia
image processing
imaging/image analysis:

clinical
imaging/image analysis:

non-clinical
imaging methods (CT, FA,
ICG, MRI, OCT, RTA, SLO,
ultrasound)
immune tolerance/privilege
immunohistochemistry
immunomodulation/immuno

regulation
infant vision
inflammation
inflow/ciliary body
3/6
inhibitory neurotransmitters
inhibitory receptors
injection
inner retina dysfunction:

biochemistry and cell biology
inner retina dysfunction:

hereditary
innervation: neural

regulation
innervation: sensation
in situ hybridization
intraocular lens
intraocular pressure
ion channels
ion transporters
iris
ischemia
keratitis
keratoconus
keratoprostheses
lacrimal gland
lamina cribrosa
laser
learning
Leber congenital amaurosis
lesion study
linkage analysis
ipofuscin
lipids
low vision
macula/fovea
macular dystrophy, inherited
macular holes
macular pigment
melanocytes
melanoma
melatonin
memory
metabolism
microbial pathogenesis:

clinical studies
microbial pathogenesis:

experimental studies
microglia
microscopy:

confocal/tunneling
microscopy: electron

microscopy
microscopy: fixation

processing
microscopy:
light/fluorescence/immunoh
istochemistry
mitochondria
molecular diagnostics
motion-2D
motion-3D
Muller cells
mutations
myopia
NaK ATPase
neovascularization
nerve fiber layer
neuro-ophthalmology:
cortical
function/rehabilitation
neuro-ophthalmology:

diagnosis
neuro-ophthalmology: optic

nerve
EuroVisionNet – Portal / Presentation Research Groups / Data
neuropeptides
neuroprotection
neurotransmitters/neurotra

nsmitter systems
nitric oxide
nutritional factors
nystagmus
ocular irritancy/toxicity

testing
ocular irritants
ocular motor control
oligodendrocyte
oncology
opsins
aberrations
optic disc
optic flow
optic nerve
optical properties
orbit
outflow: ciliary muscle
outflow: trabecular

meshwork
oxidation/oxidative or free

radical damage
oxygen
pathobiology
pathology: experimental
pathology: human
pathology techniques
pattern vision
perception
perimetry
pH
pH regulation/protons
phagocytosis and killing
phosphorylation
photodynamic therapy
photoreceptors
photoreceptors: visual

performance
plasticity
posterior capsular

opacification (PCO)
presbyopia
proliferation
proliferative

vitreoretinopathy
protective mechanisms
protein modifications-post

translational
protein purification and

characterization
protein structure/function
proteins encoded by disease

genes
proteoglycans/glycosaminog

lycans
proteolysis
proteomics
pseudomonas
pterygium
pump/barrier function
pupil
pupillary reflex
quality of life
radiation damage: light/UV
radiation therapy
reading
receptive fields
receptors
receptors:

pharmacology/physiology
refraction
refractive error development
refractive surgery
refractive surgery:

comparative studies
refractive surgery:

complications
refractive surgery: corneal

topography
refractive surgery: other

technologies
refractive surgery: LASIK
refractive surgery: optical

quality
refractive surgery: phakic

IOL
refractive surgery: PRK
regeneration
retina
retina: distal
(photoreceptors, horizontal
cells, bipolar cells)
retina: neurochemistry
retina: proximal (bipolar,

amacrine, and ganglion cells)
retinal adhesion
retinal connections,

networks, circuitry
retinal culture
retinal degenerations: cell

biology
retinal degenerations:

hereditary
retinal detachment
retinal development
retinal glia
retinal neovascularization
retinal pigment epithelium
retinitis
retinitis pigmentosa
retinoblastoma
retinochoroiditis
retinoids/retinoid binding

proteins
retinopathy of prematurity
ribosomal RNA
sclera
screening for amblyopia and

strabismus
second messengers
second messengers:

pharmacology/physiology
shape and contour
shape, form, contour, object

perception
signal transduction
signal transduction:

pharmacology/physiology
small incision cataract

surgery
space and scene perception
spectacle lens
scene perception
Staphylococcus
strabismus
4/6
strabismus: diagnosis and

detection
strabismus: etiology
strabismus: treatment
stress response
superior colliculus/optic

tectum
synapse
taurine
temporal vision
texture
thalamus/lateral geniculate

nucleus
topography
toxoplasmosis
trabecular meshwork
trachoma
training/teaching cataract

surgery
transcription
transcription factors
transgenics/knock-outs
transplantation
trauma
treatment outcomes of

cataract surgery
tumors
uvea
uveitis-clinical/animal model
varicella zoster virus
vascular endothelial growth

factor
vascular occlusion/vascular

occlusive disease
VEI
vergence
vestibulo-ocular reflex
vision and action
visual acuity
visual cortex
visual development
visual development: infancy

and childhood
visual fields
visual impairment: neuro
ophthalmological disease
visual search
vitamin A deficiency
vitreoretinal surgery
vitreoretinopathies
vitreous
vitreous substitutes
wound healing
EuroVisionNet – Portal / Presentation Research Groups / Data
5/6
2
Further Comments
EuroVisionNet – Portal / Presentation
Research Groups / Data
6/6